Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03398148 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

NCT03518086 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

NCT01336465 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

NCT00628433 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

NCT01164904 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT06979336 ·Status: RECRUITING ·Phase: PHASE2

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

NCT00729872 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

NCT03398135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992 ·Status: COMPLETED ·Phase: PHASE3

Low Dose IL-2 for Ulcerative Colitis

NCT02200445 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

NCT06619990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

NCT05121402 ·Status: WITHDRAWN ·Phase: PHASE2

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT00001184 ·Status: RECRUITING

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

NCT04898348 ·Status: WITHDRAWN ·Phase: PHASE2

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT02840721 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

NCT00659802 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

NCT02100696 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Dose-finding IMU-838 for Ulcerative Colitis

NCT03341962 ·Status: TERMINATED ·Phase: PHASE2

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

NCT03675477 ·Status: COMPLETED ·Phase: PHASE2

A Study of MDX-1100 in Subjects With Active Ulcerative Colitis

NCT00656890 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

NCT00096655 ·Status: COMPLETED ·Phase: PHASE3

Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis

NCT01036022 ·Status: COMPLETED ·Phase: PHASE2